Amgen "outperform," target price reduced

12.03.07 - Bear Stearns

NEW YORK, March 12 (newratings.com) - Analysts at Bear Stearns reiterate their "outperform" rating on Amgen Inc (AMGN). The target price has been reduced from $77 to $75.